A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats

  • Authors:
    • Yuichiro Toda
    • Toru Takahashi
    • Kyoichiro Maeshima
    • Hiroko Shimizu
    • Kazuyoshi Inoue
    • Hiroshi Morimatsu
    • Emiko Omori
    • Mamoru Takeuchi
    • Reiko Akagi
    • Kiyoshi Morita
  • View Affiliations

  • Published online on: February 1, 2007     https://doi.org/10.3892/ijmm.19.2.237
  • Pages: 237-243
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hemorrhagic shock followed by resuscitation (HSR) causes neutrophil sequestration in the lung which leads to acute lung injury (ALI). Neutrophil elastase (NE) is thought to play a pivotal role in the pathogenesis of ALI. This study investigated whether sivelestat, a specific NE inhibitor, can attenuate ALI induced by HSR in rats. Male Sprague-Dawley rats were subjected to hemorrhagic shock by withdrawing blood so as to maintain a mean arterial blood pressure of 30±5 mm Hg for 60 min followed by resuscitation with the shed blood. HSR-treated animals received a bolus injection of sivelestat (10 mg/kg) intravenously at the start of resuscitation followed by continuous infusion for 60 min (10 mg/kg/h) during the resuscitation phase, or the vehicle. Lung injury was assessed by pulmonary histology, lung wet-weight to dry-weight (W/D) ratio, myeloperoxidase (MPO) activity, gene expression of tumor necrosis factor (TNF)-α and inducible nitric oxide synthase (iNOS), DNA binding activity of nuclear factor (NF)-κB, and immunohistochemical analysis of intercellular adhesion molecule (ICAM)-1. HSR treatment induced lung injury, as demonstrated by pulmonary edema with infiltration of neutrophils, the increase in lung W/D ratio, MPO activity, gene expression of TNF-α and iNOS, and DNA-binding activity of NF-κB, and enhanced expression of ICAM-1. In contrast, sivelestat treatment significantly ameliorated the HSR-induced lung injury, as judged by the marked improvement in all these indices. These results indicate that sivelestat attenuated HSR-induced lung injury at least in part through an inhibition of the inflammatory signaling pathway, in addition to the direct inhibitory effect on NE.

Related Articles

Journal Cover

February 2007
Volume 19 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Toda Y, Takahashi T, Maeshima K, Shimizu H, Inoue K, Morimatsu H, Omori E, Takeuchi M, Akagi R, Morita K, Morita K, et al: A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats. Int J Mol Med 19: 237-243, 2007
APA
Toda, Y., Takahashi, T., Maeshima, K., Shimizu, H., Inoue, K., Morimatsu, H. ... Morita, K. (2007). A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats. International Journal of Molecular Medicine, 19, 237-243. https://doi.org/10.3892/ijmm.19.2.237
MLA
Toda, Y., Takahashi, T., Maeshima, K., Shimizu, H., Inoue, K., Morimatsu, H., Omori, E., Takeuchi, M., Akagi, R., Morita, K."A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats". International Journal of Molecular Medicine 19.2 (2007): 237-243.
Chicago
Toda, Y., Takahashi, T., Maeshima, K., Shimizu, H., Inoue, K., Morimatsu, H., Omori, E., Takeuchi, M., Akagi, R., Morita, K."A neutrophil elastase inhibitor, sivelestat, ameliorates lung injury after hemorrhagic shock in rats". International Journal of Molecular Medicine 19, no. 2 (2007): 237-243. https://doi.org/10.3892/ijmm.19.2.237